Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Study ID: NCT07187830
Start Date: 2026-02-15
End Date: 2028-01-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment
Sponsor

University of Alberta

Source: clinicaltrials.gov

Share:
Add to list

The Effectiveness of the Twin Block and Carriere Motion Appliances in Post-pubertal Patients and an Evaluation of the Impact of Class II Malocclusion and Its Correction on Oral Health-related Quality of Life

Study ID: NCT07292636
Start Date: 2026-03
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

88

Intervention / Treatment

CTB

CMA

Sponsor

Aslam Alakdheemi

Source: clinicaltrials.gov

Share:
Add to list

Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening

Study ID: NCT06549036
Start Date: 2026-03-23
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

228

Intervention / Treatment

Veteran Peer Decision Coaching Session for PSA Screening

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Study ID: NCT07222332
Start Date: 2026-03
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

Baricitinib

Placebo

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

Study of the Correlation Between Cortical Excitability and Cytoarchitectonics of Prefrontal Cortex in Healthy Adult Participants, Using Transcranial Magnetic Stimulation Coupled to EEG and High-field MRI

Study ID: NCT07071259
Start Date: 2026-03-31
End Date: 2028-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

TMS Stimulation

Sponsor

National Institute of Health and Medical Research, France

Source: clinicaltrials.gov

Share:
Add to list

Prediction of Postoperative Pulmonary Complications in Thoracic Surgery

Study ID: NCT07359885
Start Date: 2026-06-01
End Date: 2029-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Evaluation of prognostic performance of a defined score using a machine learning method (STABL: Stability Selection) integrating immune data (cytometric and proteomic)

Sponsor

University Hospital, Rouen

Source: clinicaltrials.gov

Share:
Add to list

NobelZygoma TiUltra Implant System Study

Study ID: NCT07258940
Start Date: 2026-06-01
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

85

Intervention / Treatment

NobelZygoma™ 0° CC TiUltra™implant ; NobelZygoma™ 45° Ext Hex TiUltra™ implant

Multi-Unit Abutment Xeal Zygoma Ext Hex RP; 17° Multi-Unit Abutment Xeal Zygoma Ext Hex RP; 45° Multi.Unit Abutment Xeal Zygoma CC RP; 60° Multi-Unit Abutment Xeal Zygoma CC RP

Sponsor

Nobel Biocare

Source: clinicaltrials.gov

Share:
Add to list

Stratification and Treatment in Early Psychosis Study -ASSIST

Study ID: NCT07326124
Start Date: 2026-06
End Date: 2029-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

250

Intervention / Treatment

CBD 100 mg/mL Oral Solution

Placeb

Sponsor

University of Oxford

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

Study ID: NCT04457076
Start Date: 2026-06-01
End Date: 2032-06-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1525

Intervention / Treatment

LevoCept

Sponsor

Sebela Women's Health Inc.

Source: clinicaltrials.gov

Share:
Add to list

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Study ID: NCT02988297
Start Date: 2026-10
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

140

Intervention / Treatment

RNS60

Placebo

Sponsor

Revalesio Corporation

Source: clinicaltrials.gov

Share:
Add to list